[Medicine heaven and earth] independent price negotiation between medical institutions and pharmaceutical enterprises? General manager of Tiansheng pharmaceutical is detained? Net red pharmacist Ji Lianmei is punished? Danshen injection was recalled, 7 pharmaceutical companies GMP

The government keeps promise and pharmaceutical enterprises are rewarded with special funds On May 4, 2018, Sichuan food and Drug Administration issued a notice on the issuance of consistency evaluation award funds to Sichuan Kelun Pharmaceutical Co., Ltd since the enterprise's escitalopram oxalate tablets (gyzz h20080788) were approved to pass the consistency evaluation of quality and efficacy of generic drugs, the authority issued in accordance with the notice on printing and distributing (csyjf [2017] No 45) ）It is stipulated that, upon deliberation and approval of the director general's office meeting on April 24, 2018, the commitment will be finally fulfilled, and a reward fund of 1.5 million yuan will be issued to Sichuan Kelun Pharmaceutical Co., Ltd The supervision of vaccine circulation has become a key point The provincial authorities have announced the distribution of vaccines The control of the cold chain distribution process of vaccines directly affects the quality of vaccines Some vaccines are extremely demanding on the environment, and a little carelessness will threaten their safety and effectiveness Therefore, the relevant departments pay special attention to the distribution management of vaccines In recent days, several provinces have announced the distribution of vaccines in the region For details, see the following table: pharmaceutical enterprises have entered the "deep water area" under GMP supervision, and are often eliminated from the Bureau on April 28, 2018 Anhui food and Drug Administration issued a notice on the withdrawal of the GMP certificate of Anhui Pujian decoction pieces Co., Ltd Anhui Pujian Herbal Pieces Co., Ltd is suspected of serious illegal production of herbal pieces Therefore, according to the relevant regulations, the authorities withdraw the GMP certificate of the enterprise according to law On May 2, 2018, Sichuan Pharmaceutical machinery procurement supervision network issued two announcements, stopping the online procurement of 8 drugs and Listing 2 pharmaceutical enterprises in the general adverse records According to the announcement, the GMP of Hubei Minkang Pharmaceutical Co., Ltd and Jilin Yizheng Pharmaceutical Group Co., Ltd were withdrawn, and the two pharmaceutical enterprises whose GMP certificates were withdrawn were listed in the general adverse records Meanwhile, six drugs such as norfloxacin capsule produced by Hubei Minkang Pharmaceutical Co., Ltd and two drugs such as Qizhi Jiangtang Capsule produced by Jilin Yizheng Pharmaceutical Group Co., Ltd were cancelled to participate in Sichuan Province Centralized classification of procurement qualifications and results On the same day, Yunnan food and Drug Administration issued a notice to withdraw the GMP certificate of Kunming Pharmaceutical Group (600422 SH) According to the announcement, kunyao Group Co., Ltd has seriously violated the provisions of the pharmaceutical production quality management specifications According to Article 33 of the measures for the administration of the certification of the pharmaceutical production quality management specifications, our bureau has withdrawn its GMP certificate according to law, but it is worth noting that the production of Xuesaitong preparation, which the pharmaceutical enterprise has become rich by making a fortune, has not been affected On May 3, 2018, Shanxi food and Drug Administration collectively interviewed the main principals of Linfen Baozhu Pharmaceutical Co., Ltd., Shanxi Yunpeng Pharmaceutical Co., Ltd and Shanxi Huawei Pharmaceutical Co., Ltd At the same time, due to the serious violation of the provisions of the "drug production quality management specification", the above-mentioned three enterprises interviewed were successively withdrawn their "GMP certificate" in accordance with the law The "sequel" of GSP's recovery and cancellation hit, with three more enterprises and 10 stores taking the lead On May 2, 2018, Baiyin pharmaceutical regulatory bureau of Gansu Province issued the announcement on the recovery of GSP certificate in the 6th issue in 2018 It was decided to withdraw the GSP certificate of drugs issued by Wangjiashan branch of Gansu yirentang Pharmaceutical Co., Ltd On May 3, 2018, Henan Pingdingshan pharmaceutical regulatory bureau issued the notice of cancellation of drug trade license According to the drug related laws, regulations and management measures, the application for cancellation of drug business license and related materials of ten stores including Changqiao No.1 Branch of Jiaxian County submitted by Henan love pharmacy Co., Ltd were reviewed After the study and decision, the authorities agreed to cancel the drug business licenses of the above 10 enterprises according to law For details, see the following table: on May 4, 2018, Jiangxi Provincial Drug Administration issued two replies, agreed to cancel the drug business license of Jiangxi haoyaoshida pharmacy chain Co., Ltd., note the drug business license of Jiangxi health pharmacy chain Co., Ltd., and withdraw the GSP certificate At the same time, the two companies are not allowed to engage in drug trading activities since the date of spontaneous documents The number of pieces of traditional Chinese medicine was tested again, and the number of unqualified pieces "far exceeded" that of other preparations On May 4, 2018, Gansu Provincial Drug Administration issued the drug quality announcement According to the relevant management laws and regulations, the bureau announced 29 batches of Chinese herbal pieces that failed in the inspection It is worth noting that among these 29 batches of Chinese herbal pieces, 3 batches were labeled as production enterprises and denied as production enterprises Six inspection institutions, including Heilongjiang food and drug inspection and testing institute, inspected five batches of drugs (preparations) produced by five enterprises, such as Jilin mizhikang Pharmaceutical Co., Ltd., and 13 batches of Chinese herbal pieces produced by eight enterprises, such as Hebei Zhijia Pharmaceutical Co., Ltd., and 18 batches of drugs were unqualified The relevant information is hereby announced as follows On May 3, 2018, Guangdong Provincial Food and Drug Administration issued the notice on the information of drug random inspection (No 4, 2018) After verification and confirmation, the general situation of sampling inspection information in this period is: 840 batches of 382 varieties meet the requirements of drug standards after inspection, and 13 batches of 11 varieties do not meet the requirements of drug standards after inspection See the following table for details of its unqualified drugs: pinfu: Broadcast hot spots online, and recent important industry news in the bag broadcast 1: Danshen injection was recalled Sichuan Shenghe Pharmaceutical Co., Ltd reported that due to the aggregation adverse reactions of 1801128 batches of Danshen injection (10ml) in some regions, the company took the initiative to carry out a secondary recall of the batch of products involved The progress of the recall is shown in the following figure: information broadcast II: the legal representative of Dongcheng procurement and supply station of Shaanxi Huayuan Pharmaceutical Group Co., Ltd with 8 persons producing and selling fake drugs of up to ten million yuan was appointed as the legal representative of 8 persons producing and selling fake drugs, and the trial was held in Xi'an middle court These eight people have long been in the name of "Dongcheng collection and supply station" herbal pieces department, producing herbal pieces and selling them to pharmacies and hospitals, and selling more than 12.04 million yuan of fake drugs Due to the serious circumstances of the case, the procuratorial organ believes that any eight defendants have violated the National Drug Administration regulations and knowingly produced and sold fake drugs Therefore, the criminal responsibility of Ren and other 7 people will be investigated for the crime of producing and selling fake drugs, and the defendant Liu should be investigated for the criminal responsibility for the crime of selling fake drugs Information broadcast 3: Wang Hongyao was punished as a "Ji Lianmei pharmacist" who had questioned the efficacy and safety of pidomode at the beginning of this year He was fined 1200 yuan last month for claiming to be "China's first pharmacist" by the industrial and commercial department for violating the advertising law Recently, some media questioned WeChat's official account, "Ji Lian Mei pharmacist", who earned profits by writing black net to attract fans and collecting pharmacist's joining fees Julin Mei immediately replied to his WeChat official account and micro-blog, "this is a fake" In this regard, Xiaobian laments that in the season when drug companies and drug dealers are in trouble, under the strict implementation of the advertising law, how can online Red pharmacists win this "challenge war"? We'll see Information broadcast 4: on May 4, the leading group of drug bidding and purchasing in Jiangxi Province issued a notice From now on, all the drugs that have been officially incorporated into the medical purchasing service platform of Jiangxi Province can be purchased by the medical institutions through independent negotiation with the enterprises in the purchasing platform according to relevant regulations Information broadcast 5: on May 7, the general manager of Tiansheng pharmaceutical was detained Tiansheng Pharmaceutical Group Co., Ltd (hereinafter referred to as "Tiansheng pharmaceutical") announced that on May 5, 2018 (Saturday), it was informed by relevant departments that the general manager of the company was detained by relevant departments The general manager is temporarily unable to perform relevant duties, and the company will convene the board of directors as soon as possible to recommend the director to act as chairman of the board of directors Content source: global network, cypress blue, dandelion, local medical station, official website of Provincial Drug Administration